Henar Vázquez-Villa

12PUBLICATIONS
26CO-AUTHORS
Biologically active moleculesMicrobial geneticsMolecular medicineMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 10, 2026
Discovery of Novel Synthetic Cyclohexene-Based Small Molecules Targeting Senescence against Age-Related Pulmonary Fibrosis.

|May 31, 2024
Cancer-Stem-Cell Phenotype-Guided Discovery of a Microbiota-Inspired Synthetic Compound Targeting NPM1 for Leukemia.

Sergio Algar, Henar Vázquez-Villa, Pedro Aguilar-Garrido

|Aug 31, 2022
2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson's Disease.

Javier García-Cárceles, Henar Vázquez-Villa, José Brea

|Aug 26, 2022
New Trends in Aging Drug Discovery.

Bellinda Benhamú, Mar Martín-Fontecha, Henar Vázquez-Villa

|Aug 10, 2022
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice.

Nora Khiar-Fernández, Debora Zian, Henar Vázquez-Villa

|Mar 29, 2022
Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "Diabesity".

Juan M Decara, Henar Vázquez-Villa, José Brea

Pageof 2

Frequent Collaborators

10 joint publications

María L López-Rodríguez

5 joint publications

Bellinda Benhamú

3 joint publications

Javier García-Cárceles

3 joint publications

Sergio Algar